CTMX
CTMX
US23284F1057
CytomX Therapeutics, Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 75/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±142.1% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 2.2x as much as the broader market.

Beta (Market Relation)
2.2x
Above average
Volatility (5Y p.a.)
142.1% p.a.
5-Year Horizon
Max Drawdown (5Y)
-94.2%
5-Year Horizon
Sharpe Ratio
-0.11
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -26.7%
3 Years 170.3% -91.6% 0.14 +26.5%
5 Years 142.1% -94.2% -0.11 -12.6%
10 Years 111.4% -98.7% -0.17 -16.5%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 2.20 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (170.3%) is noticeably higher than the 5Y average (142.1%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (142.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -98.7% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
6 ISS Score: 6 / 10
Audit Risk
5 ISS Score: 5 / 10
Board Risk
9 ISS Score: 9 / 10
Short Ratio
11.02
ende